Spots Global Cancer Trial Database for metronomic cyclophosphamide
Every month we try and update this database with for metronomic cyclophosphamide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors | NCT01661400 | Glioma Neuroectodermal... Wilms Tumor Rhabdomyosarcom... Sarcoma, Ewing Osteosarcoma Retinoblastoma | Metronomic Cycl... Thalidomide | 6 Months - 21 Years | Washington University School of Medicine | |
| Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients | NCT02755844 | Recurrent Endom... | Olaparib metformin metronomic cycl... | 18 Years - 81 Years | Hospices Civils de Lyon | |
| Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors | NCT02838342 | Neuroendocrine ... | Metronomic cycl... Interferon-alph... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer | NCT01526499 | Breast Cancer | Docetaxel and C... Docetaxel (T) | 18 Years - 70 Years | Fudan University | |
| Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes | NCT01910870 | Metastatic Brea... | Cisplatin Metronomic Cycl... | 18 Years - | Centre Jean Perrin | |
| Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | NCT01947062 | Lung Cancer Squamous Cell C... Locally Advance... | Intravenous Cis... Intravenous Cis... | 18 Years - 75 Years | Swami Rama Cancer Hospital and Research Institute | |
| Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients | NCT02755844 | Recurrent Endom... | Olaparib metformin metronomic cycl... | 18 Years - 81 Years | Hospices Civils de Lyon | |
| Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide | NCT03139851 | Metastatic Brea... | Cyclophosphamid... Pembrolizumab 1... | 18 Years - | Centre Leon Berard | |
| Phase II ABT-888 With Cyclophosphamide | NCT01306032 | Ovarian Cancer Primary Periton... Serous Carcinom... Triple-Negative... Fallopian Tube ... | ABT-888 Cyclophosphamid... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes | NCT01910870 | Metastatic Brea... | Cisplatin Metronomic Cycl... | 18 Years - | Centre Jean Perrin | |
| Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors | NCT02838342 | Neuroendocrine ... | Metronomic cycl... Interferon-alph... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | NCT01947062 | Lung Cancer Squamous Cell C... Locally Advance... | Intravenous Cis... Intravenous Cis... | 18 Years - 75 Years | Swami Rama Cancer Hospital and Research Institute | |
| A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer | NCT02117024 | Non Small Cell ... | Viagenpumatucel... Metronomic Cycl... Physician's Cho... | 18 Years - | Heat Biologics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
